GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Suzhou Basecare Medical Corp 2170.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.33

+1.53%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥233.3m

FY2018FY2025

Net income

−CN¥223.5m

FY2018FY2025

Free cash flow

−CN¥243.4m

FY2018FY2025

Shareholders' equity

CN¥935.1m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥233.3mCN¥255.7mCN¥177.8mCN¥120.5mCN¥107.3mCN¥81.1mCN¥55.7mCN¥27.9m
Gross profitCN¥123.6mCN¥116.5mCN¥78.1mCN¥50.9mCN¥51.1mCN¥27.7mCN¥26.3mCN¥7.0m
Research and developmentCN¥106.4mCN¥115.6mCN¥110.8mCN¥102.4mCN¥73.7mCN¥34.5mCN¥19.9mCN¥16.1m
Operating income−CN¥225.9m−CN¥197.5m−CN¥165.6m−CN¥107.8m−CN¥124.5m−CN¥880.0m−CN¥8.7m−CN¥44.3m
Net income−CN¥223.5m−CN¥202.6m−CN¥163.9m−CN¥105.3m−CN¥143.7m−CN¥877.1m−CN¥531.3m−CN¥132.4m
Diluted earnings per share-0.82-0.74-0.60-0.38-0.53-3.25-1.99-0.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥1.45bnCN¥1.43bnCN¥1.90bnCN¥1.78bnCN¥1.80bnCN¥350.3mCN¥151.1mCN¥126.7m
Cash and short-term investmentsCN¥447.3mCN¥585.3mCN¥945.7mCN¥1.33bnCN¥1.52bnCN¥192.3mCN¥56.2mCN¥59.1m
Total liabilitiesCN¥512.0mCN¥450.9mCN¥500.0mCN¥188.3mCN¥85.8mCN¥69.0mCN¥1.10bnCN¥478.9m
DebtCN¥343.5mCN¥280.8mCN¥281.9mCN¥75.5mCN¥48.6mCN¥31.5mCN¥32.6mCN¥21.2m
Shareholders' equityCN¥935.1mCN¥977.2mCN¥1.40bnCN¥1.59bnCN¥1.72bnCN¥281.3m−CN¥938.9m−CN¥348.4m
Shares outstanding274m274m274m274m274m270m267m274m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−CN¥160.0m−CN¥195.9m−CN¥228.5m−CN¥188.8m−CN¥197.9m−CN¥64.3m−CN¥38.1m−CN¥22.8m
Capital spending−CN¥83.4m−CN¥79.8m−CN¥89.1m−CN¥128.8m−CN¥36.9m−CN¥8.1m−CN¥2.4m−CN¥3.9m
Free cash flow−CN¥243.4m−CN¥275.6m−CN¥317.5m−CN¥317.5m−CN¥234.7m−CN¥72.4m−CN¥40.5m−CN¥26.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥64.4mCN¥64.4mCN¥66.0mCN¥66.0mCN¥50.7mCN¥50.7mCN¥74.5mCN¥87.2m
Gross profitCN¥34.7mCN¥34.7mCN¥35.2mCN¥35.2mCN¥26.6mCN¥26.6mCN¥33.5mCN¥39.2m
Operating income−CN¥34.4m−CN¥34.4m−CN¥49.1m−CN¥49.1m−CN¥57.9m−CN¥57.9m−CN¥48.4m−CN¥56.7m
Net income−CN¥36.0m−CN¥36.0m−CN¥51.0m−CN¥51.0m−CN¥60.7m−CN¥60.7m−CN¥50.1m−CN¥58.6m
Diluted earnings per share-0.13-0.13-0.19-0.19-0.22-0.22-0.18-0.21
Cash from operations——−CN¥33.0m−CN¥33.0m−CN¥50.0m−CN¥50.0m−CN¥45.0m−CN¥53.0m
Capital spending——−CN¥16.0m−CN¥16.0m−CN¥25.0m−CN¥25.0m−CN¥16.0m−CN¥18.0m
Free cash flow——−CN¥49.0m−CN¥49.0m−CN¥75.0m−CN¥75.0m−CN¥61.0m−CN¥71.0m
Total assetsCN¥1.33bnCN¥1.33bnCN¥1.45bnCN¥1.45bnCN¥1.57bnCN¥1.57bnCN¥1.67bnCN¥1.67bn
Cash and short-term investmentsCN¥378.4mCN¥378.4mCN¥443.0mCN¥445.5mCN¥545.5mCN¥545.5mCN¥684.6mCN¥687.2m
DebtCN¥79.9mCN¥79.9mCN¥343.4mCN¥54.0mCN¥342.2mCN¥37.1mCN¥328.4mCN¥28.8m
Shareholders' equityCN¥864.8mCN¥864.8mCN¥934.7mCN¥934.7mCN¥1.03bnCN¥1.03bnCN¥1.14bnCN¥1.14bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue24.6%23.5%—
Operating income28.0%-23.8%—
Net income28.5%-23.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin49.1%46.9%45.9%—
Operating margin-86.6%-88.5%-174.4%—
Net margin-87.1%-88.3%-175.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-2.0-3.2-3.4-8.4-11.0
Price to sales1.92.53.17.314.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.